Journal Watch 17/04/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Endoscopic sleeve gastroplasty more cost-effective than with semaglutideAn economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is...
NICE approves endoscopic sleeve gastroplasty for weight loss managementThe UK’s National Institute for Health and Care Excellence (NICE) has approved the use of endoscopic sleeve gastroplasty (ESG) for weight...
ESG safe, effective and durable for patients with in class III obesityWhen combined with longitudinal nutritional support, endoscopic sleeve gastroplasty (ESG) is a safe and effective tool for adults with...
Journal watch 03/08/2022Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Journal watch 20/07/2022Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Updates on endoscopic bariatric therapies from DDWFour studies presented at this year’s Digestive Disease Week have highlighted the benefits endoscopic bariatric therapies as primary and...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes7 days ago